TLR9 and breast carcinoma: Although TLR9 is expressed in all clinically relevant subtypes of breast cancer, we and others have discovered that there is an inverse correlation between tumor TLR9 and ER expression: ER-positive breast cancers have significantly lower levels of TLR9 expression, as compared with TNBCs (26, 29, 32, 36).